at Nasdaq.com (Nov 17, 2014)
Specialized chemical maker Chemtura (CHMT +2.9%) trades up on an otherwise down day, after Longbow Research upgraded the shares to a Buy with a $26 price target. The firm cites a number of catalysts, including the company's acquisition of Solaris' bromine assets, a reinvigorated AgroSolutions pipeline, and an eventual divestiture of it's consumer products. The stock has been a solid performer this year, up over 86% YTD.
From other sites
at Zacks.com (Oct 31, 2014)
at CNBC.com (Aug 26, 2014)
at MarketWatch.com (Mar 16, 2012)